Adam K Klein

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Nature communications

Drug testing and analysis

UC San Diego Health System

University of California (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UC San Diego Health System Jul 01 2018

United States

Postdoctoral Fellow :: Psychiatry

Education History

University of California - Jun 30 2018

United States

PHD :: Psychological & Brain Sciences

Publications

Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2024)
Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)
Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)
Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2024)
Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)
Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)
Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)
Jason Wallach, Andrew B Cao, Maggie M Calkins, Andrew J Heim, Janelle K Lanham, Emma M Bonniwell, Joseph J Hennessey, Hailey A Bock, Emilie I Anderson, Alexander M Sherwood, Hamilton Morris, Robbin de Klein, Adam K Klein, Bruna Cuccurazzu, James Gamrat, Tilka Fannana, Randy Zauhar, Adam L Halberstadt, John D McCorvy
Identification of 5-HT 2A receptor signaling pathways associated with psychedelic potential. Nature communications 14 (1) (2023)
Jason Wallach, Andrew B Cao, Maggie M Calkins, Andrew J Heim, Janelle K Lanham, Emma M Bonniwell, Joseph J Hennessey, Hailey A Bock, Emilie I Anderson, Alexander M Sherwood, Hamilton Morris, Robbin de Klein, Adam K Klein, Bruna Cuccurazzu, James Gamrat, Tilka Fannana, Randy Zauhar, Adam L Halberstadt, John D McCorvy
Identification of 5-HT 2A receptor signaling pathways associated with psychedelic potential. Nature communications 14 (1) (2023)
Jason Wallach, Andrew B Cao, Maggie M Calkins, Andrew J Heim, Janelle K Lanham, Emma M Bonniwell, Joseph J Hennessey, Hailey A Bock, Emilie I Anderson, Alexander M Sherwood, Hamilton Morris, Robbin de Klein, Adam K Klein, Bruna Cuccurazzu, James Gamrat, Tilka Fannana, Randy Zauhar, Adam L Halberstadt, John D McCorvy
Identification of 5-HT 2A receptor signaling pathways associated with psychedelic potential. Nature communications 14 (1) (2023)
Jason Wallach, Andrew B Cao, Maggie M Calkins, Andrew J Heim, Janelle K Lanham, Emma M Bonniwell, Joseph J Hennessey, Hailey A Bock, Emilie I Anderson, Alexander M Sherwood, Hamilton Morris, Robbin de Klein, Adam K Klein, Bruna Cuccurazzu, James Gamrat, Tilka Fannana, Randy Zauhar, Adam L Halberstadt, John D McCorvy
Identification of 5-HT 2A receptor signaling pathways associated with psychedelic potential. Nature communications 14 (1) (2023)
Simon D Brandt, Pierce V Kavanagh, Folker Westphal, Alexander Stratford, Anna U Odland, Adam K Klein, Geraldine Dowling, Nicola M Dempster, Jason Wallach, Torsten Passie, Adam L Halberstadt
Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD). Drug testing and analysis 12 (6) (2020)

Adam K Klein.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Adam K Klein